Large-scale meta-analysis of genome-wide association data identifies six new risk loci for Parkinson’s disease

Cited by (1,004)

Items 301–400 of 1,004

1. Genome-wide Association Analysis of Parkinson’s Disease and Schizophrenia Reveals Shared Genetic Architecture and Identifies Novel Risk Loci
   Olav Bjerkehagen Smeland, Alexey A. Shadrin, Shahram Bahrami, Iris Broce, Martin Tesli, Oleksandr Frei, Katrine Verena Wirgenes, Kevin Sean O’Connell, Florian Krull, Francesco Bettella et al. · 2020 · Biological Psychiatry
2. Epigenomic analysis of Parkinson’s disease neurons identifies Tet2 loss as neuroprotective
   Lee L. Marshall, Bryan A. Killinger, Elizabeth Ensink, Peipei Li, Katie X. Li, Wei Cui, Noah Lubben, Matthew J. Weiland, Xinhe Wang, Juozas Gordevičius et al. · 2020 · Nature Neuroscience
3. Correction to: Picomolar concentrations of oligomeric alpha-synuclein sensitizes TLR4 to play an initiating role in Parkinson’s disease pathogenesis
   Craig D. Hughes, Minee L. Choi, Mina Ryten, Lee Hopkins, Anna Drews, Juan Antonio Botía, Maria Iljina, Margarida Rodrigues, Sarah A. Gagliano Taliun, Sonia Gandhi et al. · 2018 · Acta Neuropathologica
4. NeuroX, a fast and efficient genotyping platform for investigation of neurodegenerative diseases
   Mike A. Nalls, José Brás, Dena G. Hernandez, Margaux F. Keller, Elisa Majounie, Alan Edward Renton, Mohamad Saad, Iris E. Jansen, Rita João Guerreiro, Steven J Lubbe et al. · 2014 · Neurobiology of Aging
5. Long Non-coding RNAs Associated With Neurodegeneration-Linked Genes Are Reduced in Parkinson’s Disease Patients
   Maximilianos Elkouris, Georgia Kouroupi, Alexios Vourvoukelis, Nikolaos Papagiannakis, Valeria Kaltezioti, Rebecca Matsas, Leonidas Stefanis, Maria Xilouri, Panagiotis K. Politis · 2019 · Frontiers in Cellular Neuroscience
6. Identification of sixteen novel candidate genes for late onset Parkinson’s disease
   Alessandro Gialluisi, Mafalda Giovanna Reccia, Nicola Modugno, Teresa Nutile, Alessia Lombardi, Luca Giovanni Di Giovannantonio, Sara Pietracupa, Daniela Ruggiero, Simona Scala, Stefano Gambardella et al. · 2021 · Molecular Neurodegeneration
7. Abnormalities of age-related T cell senescence in Parkinson’s disease
   Caroline H. Williams‐Gray, Ruwani Wijeyekoon, Kirsten M. Scott, Shaista Hayat, RogerA Barker, Joanne Jones · 2018 · Journal of Neuroinflammation
8. A new hypothesis for Parkinson’s disease pathogenesis: GTPase-p38 MAPK signaling and autophagy as convergence points of etiology and genomics
   Julia Obergasteiger, Giulia Frapporti, Peter Paul Pramstaller, Andrew A. Hicks, Mattia Volta · 2018 · Molecular Neurodegeneration
9. Risk factors of levodopa-induced dyskinesia in Parkinson’s disease: results from the PPMI cohort
   Paolo Eusebi, Michele Romoli, Federico Paolini Paoletti, Nicola Tambasco, Paolo Calabresi, Lucilla Parnetti · 2018 · npj Parkinson s Disease
10. Parkinson's: A Disease of Aberrant Vesicle Trafficking
    Pawan Kishor Singh, Miratul M. K. Muqit · 2020 · Annual Review of Cell and Developmental Biology
11. Systematic tissue-specific functional annotation of the human genome highlights immune-related DNA elements for late-onset Alzheimer’s disease
    Lu, Qiongshi, Powles, Ryan L., Abdallah, Sarah, Ou, Derek, Wang, Qian, Hu, Yiming, Lu, Yisi, Liu, Wei, Li, Boyang, Mukherjee, Shubhabrata et al. · 2017 · PLOS Genetics
12. Immune responses in the Parkinson's disease brain
    Fiona C. Weiss, Adahir Labrador‐Garrido, Nicolas L. Dzamko, Glenda Margaret Halliday · 2022 · Neurobiology of Disease
13. Neuroinflammation in Lewy body dementia
    Ajenthan Surendranathan, James Benedict Rowe, John Tiernan O'Brien · 2015 · Parkinsonism & Related Disorders
14. Lrrk2 alleles modulate inflammation during microbial infection of mice in a sex-dependent manner
    Shutinoski, Bojan, Hakimi, Mansoureh, Harmsen, Irene E., Lunn, Michaela, Rocha, Juliana, Lengacher, Nathalie, Zhou, Yi Yuan, Khan, Jasmine, Nguyen, Angela, Hake-Volling, Quinton et al. · 2019 · Science Translational Medicine
15. Mitochondria: A Common Target for Genetic Mutations and Environmental Toxicants in Parkinson’s Disease
    Martin Helley, Jennifer R. Pinnell, Carolina Sportelli, Kim Tieu · 2017 · Frontiers in Genetics
16. Enhancers active in dopamine neurons are a primary link between genetic variation and neuropsychiatric disease
    Xianjun Dong, Zhixiang Liao, David Gritsch, Yavor Hadzhiev, Yunfei Bai, Joseph J. Locascio, Boris Guennewig, Ganqiang Liu, Cornelis Blauwendraat, Tao Wang et al. · 2018 · Nature Neuroscience
17. Genome-wide association study of REM sleep behavior disorder identifies polygenic risk and brain expression effects
    Lynne Krohn, Karl Heilbron, Cornelis Blauwendraat, Regina Hertfelder Reynolds, Eric Yu, Konstantin A. Senkevich, Uladzislau Rudakou, Mehrdad A. Estiar, Emil Karl Gustavsson, Kajsa Atterling Brolin et al. · 2022 · Nature Communications
18. α‐synuclein genetic variability: A biomarker for dementia in Parkinson disease
    Ilaria Guella, Daniel M. Evans, Chelsea Szu‐Tu, Ekaterina Nosova, Stephanie Bortnick, SNCA Cognition Study Group, Jennifer G. Goldman, John C. Dalrymple‐Alford, Gert J. Geurtsen, Irene Litvan et al. · 2016 · Annals of Neurology
19. Classification of advanced stages of Parkinson’s disease: translation into stratified treatments
    Rejko Krüger, Jochen Klucken, Daniel Weiß, Lars Tönges, Pierre Luc Kolber, Stefan Unterecker, Michael Lorrain, Horst K.J. Baas, Thomas H. Müller, Peter Franz Riederer · 2017 · Journal of Neural Transmission
20. Genome-Wide Association Studies of Schizophrenia and Bipolar Disorder in a Diverse Cohort of US Veterans
    Tim B. Bigdeli, Ayman H. Fanous, Yuli Li, Nallakkandi Rajeevan, Frederick G. Sayward, Giulio Genovese, Rishab Gupta, Krishnan Radhakrishnan, Anil K. Malhotra, Ning Sun et al. · 2020 · Schizophrenia Bulletin
21. Antigen-presenting innate lymphoid cells orchestrate neuroinflammation
    John B. Grigg, Arthi Shanmugavadivu, Tommy Regen, Christopher N. Parkhurst, Anees Ahmed, Ann Mary Joseph, Michael R. Mazzucco, Konrad Gronke, Andreas Diefenbach, Gérard Eberl et al. · 2021 · Nature
22. Single-cell transcriptomic and proteomic analysis of Parkinson’s disease brains
    Biqing Zhu, Jae-Min Park, Sarah Coffey, Anthony J. Russo, I-Uen Yvonne Hsu, Jiawei Wang, Chang Su, Rui B. Chang, TuKiet T. Lam, Pallavi P. Gopal et al. · 2024 · Science Translational Medicine
23. Genes associated with Parkinson's disease: regulation of autophagy and beyond
    Alexandra G. Beilina, Mark Cookson · 2015 · Journal of Neurochemistry
24. The Evolution of Genetics: Alzheimer’s and Parkinson’s Diseases
    Andrew Singleton, John Hardy · 2016 · Neuron
25. Modeling Parkinson’s Disease in Drosophila: What Have We Learned for Dominant Traits?
    Yulan Xiong, Jianzhong Yu · 2018 · Frontiers in Neurology
26. Biomarkers in Neurodegenerative Diseases
    Jeromin, Andreas, Bowser, Robert · 2017 · Advances in Neurobiology
27. Language Deficits as a Preclinical Window into Parkinson’s Disease: Evidence from Asymptomatic Parkin and Dardarin Mutation Carriers
    Adolfo M. García, Lucas Sedeño, Natalia Trujillo, Yamile Bocanegra, Diana Gómez, David A. Pineda, Andrés Villegas, Édinson Muñoz, William H. Arias, Agustín M. Ibáñez · 2017 · Journal of the International Neuropsychological Society
28. Modifiable risk and protective factors in disease development, progression and clinical subtypes of Parkinson's disease: What do prospective studies suggest?
    Daniele Belvisi, Roberta Pellicciari, Giovanni Fabbrini, Michèle Tinazzi, Alfredo Berardelli, Giovanni Defazio · 2019 · Neurobiology of Disease
29. Precision medicine in Parkinson’s disease: emerging treatments for genetic Parkinson’s disease
    Susanne A. Schneider, Roy N. Alcalay · 2020 · Journal of Neurology
30. FcγRIIB mediates the inhibitory effect of aggregated α-synuclein on microglial phagocytosis
    Yu Ree Choi, Seo‐Jun Kang, Jin-Mo Kim, Seung‐Jae Lee, Ilo Jou, Eun-hye Joe, Sang Myun Park · 2015 · Neurobiology of Disease
31. Deletions at 22q11.2 in idiopathic Parkinson's disease: a combined analysis of genome-wide association data
    Kin Ying Mok, Una‐Marie Sheerin, Javier Simón‐Sánchez, Afnan S. Salaka, Lucy A. Chester, Valentina Escott‐Price, Kiran K. Mantripragada, Karen A. Doherty, Alastair John Noyce, Niccolò Emanuele Mencacci et al. · 2016 · The Lancet Neurology
32. Association between α-synuclein blood transcripts and early, neuroimaging-supported Parkinson’s disease
    Joseph J. Locascio, Shirley W. Eberly, Zhixiang Liao, Ganqiang Liu, Ashley N. Hoesing, Karen T. Duong, Ana T. Trisini Lipsanopoulos, Kaltra Dhima, Albert Y. Hung, Alice Weaver Flaherty et al. · 2015 · Brain
33. The endocytic membrane trafficking pathway plays a major role in the risk of Parkinson's disease
    Bandres‐Ciga, Sara, Saez‐Atienzar, Sara, Bonet‐Ponce, Luis, Billingsley, Kimberley, Vitale, Dan, Blauwendraat, Cornelis, Gibbs, Jesse Raphael, Pihlstrøm, Lasse, Gan‐Or, Ziv, The International Parkinson's Disease Genomics Consortium (IPDGC) et al. · 2019 · Movement Disorders
34. Coding mutations in NUS1 contribute to Parkinson’s disease
    Jifeng Guo, Lu Zhang, Kai Li, Junpu Mei, Jin Xue, Jia Chen, Xia Tang, Lu Hua Shen, Hong Feng Jiang, Chao Chen et al. · 2018 · Proceedings of the National Academy of Sciences
35. Lipids, Apolipoproteins, and the Risk of Parkinson Disease
    Fang Fang, Yiqiang Zhan, Niklas Hammar, Xia Shen, Karin Wirdefeldt, Göran Walldius, Daniela Mariosa · 2019 · Circulation Research
36. Clioquinol rescues Parkinsonism and dementia phenotypes of the tau knockout mouse
    Peng Lei, Scott Ayton, Ambili Thoppuvalappil Appukuttan, Irene Volitakis, Paul Anthony Adlard, David Isaac Finkelstein, Ashley Ian Bush · 2015 · Neurobiology of Disease
37. The endosomal pathway in Parkinson's disease
    Rebecca M. Perrett, Zoi Alexopoulou, George K. Tofaris · 2015 · Molecular and Cellular Neuroscience
38. Role of the Long Non-Coding RNA MAPT-AS1 in Regulation of Microtubule Associated Protein Tau (MAPT) Expression in Parkinson's Disease
    Kirsten Coupland, Woojin Scott Kim, Glenda Margaret Halliday, Marianne Hallupp, Carol Dobson‐Stone, John B. Kwok · 2016 · PLoS ONE
39. Meta-Analysis of Parkinson’s Disease and Alzheimer’s Disease Revealed Commonly Impaired Pathways and Dysregulation of NRF2-Dependent Genes
    Wang, Qian, Li, Wen-Xing, Dai, Shao-Xing, Guo, Yi-Cheng, Han, Fei-Fei, Zheng, Jun-Juan, Li, Gong-Hua, Huang, Jing-Fei · 2017 · Journal of Alzheimer s Disease
40. The GBAP1 pseudogene acts as a ceRNA for the glucocerebrosidase gene GBA by sponging miR-22-3p
    Letizia Straniero, Valeria Rimoldi, Maura Samarani, Stefano Goldwurm, Alessio Di Fonzo, Rejko Krüger, Michela Deleidi, Massimo Aureli, Giulia Soldà, Stefano Duga et al. · 2017 · Scientific Reports
41. Recombinant pro-CTSD (cathepsin D) enhances SNCA/α-Synuclein degradation in α-Synucleinopathy models
    Susy Prieto Huarcaya, Alice Drobny, André R. A. Marques, Alessandro Di Spiezio, Jan Philipp Dobert, Denise Balta, Christian D. Werner, Tania Rizo, Lisa Gallwitz, Simon Bub et al. · 2022 · Autophagy
42. Synuclein impairs trafficking and signaling of BDNF in a mouse model of Parkinson’s disease
    Fang Fang, Wanlin Yang, Jazmin B. Florio, Edward M. Rockenstein, Brian J. Spencer, Xavier Orain, Stephanie X. Dong, Huayan Li, Xu‐Qiao Chen, Kijung Sung et al. · 2017 · Scientific Reports
43. Immunotherapy in Parkinson’s Disease: Micromanaging Alpha-Synuclein Aggregation
    Sonia George, Patrik Brundin · 2015 · Journal of Parkinson s Disease
44. The Luxembourg Parkinson’s Study: A Comprehensive Approach for Stratification and Early Diagnosis
    Géraldine Hipp, Michel Vaillant, Nico J. Diederich, Kirsten Roomp, Venkata Satagopam, Peter Banda, Estelle Sandt, Kathleen Mommaerts, Sabine K. Schmitz, Laura Longhino et al. · 2018 · Frontiers in Aging Neuroscience
45. Characterization of altered molecular mechanisms in Parkinson’s disease through cell type–resolved multiomics analyses
    Andrew Lee, Changyoun Kim, Seong-Wan Park, Jaegeon Joo, Baekgyu Choi, Dongchan Yang, Kyoungho Jun, Junghyun Eom, Seung‐Jae Lee, Sun Ju Chung et al. · 2023 · Science Advances
46. Linking environmental risk factors with epigenetic mechanisms in Parkinson’s disease
    Maria Tsalenchuk, Steve Gentleman, Sarah J. Marzi · 2023 · npj Parkinson s Disease
47. Pathways to Parkinsonism Redux: convergent pathobiological mechanisms in genetics of Parkinson's disease
    Kumaran, Ravindran, Cookson, Mark R. · 2015 · Human Molecular Genetics
48. Genome-wide analysis of genetic correlation in dementia with Lewy bodies, Parkinson's and Alzheimer's diseases
    Rita João Guerreiro, Valentina Escott‐Price, Lee Darwent, Laura Parkkinen, Olaf Ansorge, Dena G. Hernandez, Mike A. Nalls, Lorraine N. Clark, Lawrence S. Honig, Karen S. Marder et al. · 2015 · Neurobiology of Aging
49. Predictive model of spread of Parkinson's pathology using network diffusion
    Sneha Pandya, Yashar Zeighami, Benjamin S. Freeze, Mahsa Dadar, D. Louis Collins, Alain Dagher, Ashish Raj · 2019 · NeuroImage
50. Divergent neuronal DNA methylation patterns across human cortical development reveal critical periods and a unique role of CpH methylation
    Amanda J. Price, Leonardo Collado‐Torres, Nikolay A. Ivanov, Wei Ting Xia, Emily E. Burke, Joo Heon Shin, Ran Tao, Liang Ma, Yankai Jia, Thomas M. Hyde et al. · 2019 · Genome biology
51. Transcriptomic signatures of brain regional vulnerability to Parkinson’s disease
    Arlin Keo, Ahmed Essam Mahfouz, Angela M. T. Ingrassia, Jean‐Pascal Meneboo, Céline Villenet, Eugénie Mutez, Thomas Comptdaer, Boudewijn P. F. Lelieveldt, Martin Figeac, Marie‐Christine Chartier‐Harlin et al. · 2020 · Communications Biology
52. LRRK2, GBA and their interaction in the regulation of autophagy: implications on therapeutics in Parkinson's disease
    Shirley Yin-Yu Pang, Rachel Lo, Philip Wing‐Lok Ho, Huifang Liu, Eunice Eun Seo Chang, Chi-Ting Leung, Yasine Malki, Zoe Yuen-Kiu Choi, Wing Yan Wong, Michelle Hiu-Wai Kung et al. · 2022 · Translational Neurodegeneration
53. ɑ‐Synuclein strains and the variable pathologies of synucleinopathies
    Wouter Peelaerts, Veerle Baekelandt · 2016 · Journal of Neurochemistry
54. Genomics implicates adaptive and innate immunity in Alzheimer’s and Parkinson’s diseases
    Gagliano, Sarah A., Pouget, Jennie G., Hardy, John, Knight, Jo, Barnes, Michael R., Ryten, Mina, Weale, Michael E. · 2016 · Annals of Clinical and Translational Neurology
55. Biological functions of selenium and its potential influence on Parkinson's disease
    Joel Henrique Ellwanger, Silvia Isabel Rech Franke, Diana Lilian Bordin, Daniel Prá, João Antônio Pêgas Henriques · 2016 · Anais da Academia Brasileira de Ciências
56. Parkinson disease polygenic risk score is associated with Parkinson disease status and age at onset but not with alpha-synuclein cerebrospinal fluid levels
    Laura Ibáñez, Umber Dube, Benjamin A. Saef, John Budde, Kathleen Black, Alexandra Medvedeva, Jorge L. Del‐Aguila, Albert A. Davis, Joel S. Perlmutter, Oscar Harari et al. · 2017 · BMC Neurology
57. The lysosomal potassium channel TMEM175 adopts a novel tetrameric architecture
    Changkeun Lee, Jiangtao Guo, Weizhong Zeng, Sung‐Hoon Kim, Ji She, Chunlei Cang, Dejian Ren, Youxing Jiang · 2017 · Nature
58. Genetics of Parkinson's Disease
    Christos Koros, Athina‐Maria Simitsi, Leonidas Stefanis · 2017 · International review of neurobiology
59. Indispensable role of the Ubiquitin-fold modifier 1-specific E3 ligase in maintaining intestinal homeostasis and controlling gut inflammation
    Yafei Cai, Guangxun Zhu, SiYang Maggie Liu, Zezheng Pan, Michaela K. Quintero, Candace J. Poole, Chunwan Lu, Huabin Zhu, Bianca N. Islam, Jan van Riggelen et al. · 2019 · Cell Discovery
60. ROS networks: designs, aging, Parkinson’s disease and precision therapies
    Alexey N. Kolodkin, Raju Prasad Sharma, Anna Maria Colangelo, Andrew Ignatenko, Francesca Martorana, Danyel G. J. Jennen, Jacob J. Briedé, Nathan Ryan Brady, Matteo Barberis, Thierry D.G.A. Mondeel et al. · 2020 · npj Systems Biology and Applications
61. Eye-brain connections revealed by multimodal retinal and brain imaging genetics
    Bingxin Zhao, Yujue Li, Zirui Fan, Zhenyi Wu, Juan Shu, Xiaochen Yang, Yilin Yang, Xifeng Wang, Bingxuan Li, Xiyao Wang et al. · 2024 · Nature Communications
62. Elevated LRRK2 autophosphorylation in brain-derived and peripheral exosomes in LRRK2 mutation carriers
    Shijie Wang, Zhiyong Liu, Tao Ye, Omar S. Mabrouk, Tyler Maltbie, Jan Olav Aasly, Andrew B. West · 2017 · Acta Neuropathologica Communications
63. Convergent Genetic and Expression Datasets Highlight TREM2 in Parkinson’s Disease Susceptibility
    Guiyou Liu, Yongquan Liu, Qinghua Jiang, Yongshuai Jiang, Rennan Feng, Liangcai Zhang, Zugen Chen, Keshen Li, Jiafeng Liu · 2015 · Molecular Neurobiology
64. Mitochondrial control of cell bioenergetics in Parkinson’s disease
    Raquel Requejo-Aguilar, Juan Pedro Bolaños · 2016 · Free Radical Biology and Medicine
65. mTOR independent regulation of macroautophagy by Leucine Rich Repeat Kinase 2 via Beclin-1
    Claudia Manzoni, Adamantios Mamais, Dorien A. Roosen, Sybille Dihanich, Marc P. M. Soutar, Hélène Plun‐Favreau, Rina Bandopadhyay, John Hardy, Sharon A. Tooze, Mark Cookson et al. · 2016 · Scientific Reports
66. Identifying drug targets for neurological and psychiatric disease via genetics and the brain transcriptome
    Denis A. Baird, Jimmy Z. Liu, Jie Zheng, Solveig K. Sieberts, Thanneer Malai Perumal, Benjamin Elsworth, Tom G. Richardson, Chia‐Yen Chen, Minerva M. Carrasquillo, Mariet Allen et al. · 2021 · PLoS Genetics
67. Molecular programs of regional specification and neural stem cell fate progression in macaque telencephalon
    Nicola Micali, Shaojie Ma, Mingfeng Li, Suel–Kee Kim, Xoel Mato-Blanco, Suvimal Kumar Sindhu, Jon I. Arellano, Tianliuyun Gao, Mikihito Shibata, Kevin T. Gobeske et al. · 2023 · Science
68. Analysis of Shared Heritability in Common Disorders of the Brain
    2016
69. Parkinson's disease: SNCA-, PARK2-, and LRRK2- targeting microRNAs elevated in cingulate gyrus
    Tatura, Roman, Kraus, Theo, Giese, Armin, Arzberger, Thomas, Buchholz, Malte, Höglinger, Günter, Müller, Ulrich · 2016 · Parkinsonism & Related Disorders
70. Functionalization of the TMEM175 p.M393T variant as a risk factor for Parkinson disease
    Sarah Jinn, Cornelis Blauwendraat, Dawn M. Toolan, Cheryl A. Gretzula, Robert E. Drolet, Sean Smith, Mike A. Nalls, Jacob Marcus, Andrew Singleton, David J Stone · 2019 · Human Molecular Genetics
71. Delivering the Promise of Gene Therapy with Nanomedicines in Treating Central Nervous System Diseases
    Meihua Luo, Leo Kit Cheung Lee, Bo Peng, Chung Hang Jonathan Choi, Wing Yin Tong, Nicolas Hans Voelcker · 2022 · Advanced Science
72. LRRK2 Kinase Inhibition as a Therapeutic Strategy for Parkinson's Disease, Where Do We Stand?
    Jean‐Marc Taymans, Elisa Greggio · 2016 · Current Neuropharmacology
73. Genetics of Synucleinopathies
    Robert Luke Nussbaum · 2017 · Cold Spring Harbor Perspectives in Medicine
74. Ethnic and trans-ethnic genome-wide association studies identify new loci influencing Japanese Alzheimer’s disease risk
    Shigemizu, Daichi, Mitsumori, Risa, Akiyama, Shintaro, Miyashita, Akinori, Morizono, Takashi, Higaki, Sayuri, Asanomi, Yuya, Hara, Norikazu, Tamiya, Gen, Kinoshita, Kengo et al. · 2021 · Translational Psychiatry
75. The Trojan horse - neuroinflammatory impact of T cells in neurodegenerative diseases
    Annika Sommer, Beate Winner, Iryna Prots · 2017 · Molecular Neurodegeneration
76. DNM3 and genetic modifiers of age of onset in LRRK2 Gly2019Ser parkinsonism: a genome-wide linkage and association study
    Joanne Trinh, Emil Karl Gustavsson, Carles Vilariño‐Güell, Stephanie Bortnick, Jeanne C. Latourelle, Marna B. McKenzie, Chelsea Szu‐Tu, Ekaterina Nosova, Jaskaran Khinda, Austen J. Milnerwood et al. · 2016 · The Lancet Neurology
77. Neurite Collapse and Altered ER Ca2+ Control in Human Parkinson Disease Patient iPSC-Derived Neurons with LRRK2 G2019S Mutation
    Joanna A. Korecka, Sébastien Talbot, Teresia M. Osborn, Sherida M. de Leeuw, Simon A. Levy, Eliza J. Ferrari, Alyssa Moskites, Elise Atkinson, Francine M. Jodelka, Anthony J. Hinrich et al. · 2018 · Stem Cell Reports
78. Mutations in LRRK2 linked to Parkinson disease sequester Rab8a to damaged lysosomes and regulate transferrin-mediated iron uptake in microglia
    Adamantios Mamais, Jillian H. Kluss, Luis Bonet‐Ponce, Natalie Landeck, Rebekah G. Langston, Nathan Smith, Alexandra G. Beilina, Alice Kaganovich, Manik Chandra Ghosh, Laura Pellegrini et al. · 2021 · PLoS Biology
79. GBA and APOE ε4 associate with sporadic dementia with Lewy bodies in European genome wide association study
    Arvid Rongve, Aree Witoelar, Agustı́n Ruiz, Lavinia Athanasiu, Carla Abdelnour Ruiz, Jordi Clarimón, Stefanie Heilmann‐Heimbach, Isabel Hernández, Sonia Moreno–Grau, Itziar de Rojas et al. · 2019 · Scientific Reports
80. Sac2/INPP5F is an inositol 4-phosphatase that functions in the endocytic pathway
    Fubito Nakatsu, Mirko Messa, Ramiro Nández, Heather Czapla, Yixiao Zou, Stephen M. Strittmatter, Pietro V. De Camilli · 2015 · The Journal of Cell Biology
81. Antidepressant drug-specific prediction of depression treatment outcomes from genetic and clinical variables
    Raquel Iniesta, Karen Hodgson, Daniel R. Stahl, Karim Malki, Wolfgang Maier, Marcella Rietschel, Ole N Mors, Joanna Hauser, Neven Henigsberg, Mojca Zvezdana Dernovšek et al. · 2018 · Scientific Reports
82. Cerebrospinal fluid levels of alpha-synuclein measured using a poly-glutamic acid-modified gold nanoparticle-doped disposable neuro-biosensor system
    Münteha Nur Sonuç Karaboğa, Mustafa Kemal Sezgintürk · 2018 · The Analyst
83. Baseline genetic associations in the Parkinson's Progression Markers Initiative (PPMI)
    Mike A. Nalls, Margaux F. Keller, Dena G. Hernandez, Lan Chen, David J. Stone, Andrew Singleton, on behalf of the Parkinson's Progression Marker Initiative (PPMI) investigators · 2015 · Movement Disorders
84. Anti-α-synuclein ASO delivered to monoamine neurons prevents α-synuclein accumulation in a Parkinson's disease-like mouse model and in monkeys
    Diana Alarcón-Arís, Rubén Pavia-Collado, Lluís Miquel-Rio, Valentín Cóppola-Segovia, Albert Ferrés‐Coy, Esther Ruiz‐Bronchal, Mireia Galofré, Verónica Paz, Leticia Campa, Raquel Revilla et al. · 2020 · EBioMedicine
85. Phytochemicals as Regulators of Genes Involved in Synucleinopathies
    Andrei P. Surguchov, Libby Bernal, Alexei A. Surguchev · 2021 · Biomolecules
86. Brain gene co-expression networks link complement signaling with convergent synaptic pathology in schizophrenia
    Minsoo Kim, Jillian R. Haney, Pan Zhang, Leanna M. Hernandez, Lee-kai Wang, Laura Pérez‐Cano, Loes M. Olde Loohuis, Luis de la Torre-Ubieta, Michael J. Gandal · 2021 · Nature Neuroscience
87. Advances in protein-protein interaction network analysis for Parkinson's disease
    James E. Tomkins, Claudia Manzoni · 2021 · Neurobiology of Disease
88. Opening up the DNA methylome of dementia
    Raúl Delgado‐Morales, Manel Esteller · 2017 · Molecular Psychiatry
89. A specific amino acid motif of HLA-DRB1 mediates risk and interacts with smoking history in Parkinson’s disease
    Jill A. Hollenbach, Paul J. Norman, Lisa E. Creary, Vincent Damotte, Gonzalo Montero-Martín, Stacy J. Caillier, Kirsten M. Anderson, Maneesh Kumar Misra, Neda Nemat‐Gorgani, Kazutoyo Osoegawa et al. · 2019 · Proceedings of the National Academy of Sciences
90. Prospects of Neurotrophic Factors for Parkinson's Disease: Comparison of Protein and Gene Therapy
    Andrii Domanskyi, Märt Saarma, Mikko Airavaara · 2015 · Human Gene Therapy
91. LRRK2 recruitment, activity, and function in organelles
    Luis Bonet‐Ponce, Mark Cookson · 2021 · FEBS Journal
92. Genome-wide Association and Meta-analysis of Age at Onset in Parkinson Disease
    Sandeep Grover, Ashwin Ashok Kumar Sreelatha, Lasse Pihlstrøm, Cloé Domenighetti, Claudia Schulte, Pierre‐Emmanuel Sugier, Milena Radivojkov‐Blagojevic, Peter Lichtner, Océane Mohamed, Berta Portugal et al. · 2022 · Neurology
93. Resequencing analysis of five Mendelian genes and the top genes from genome-wide association studies in Parkinson’s Disease
    Bruno A. Benítez, Albert A. Davis, Sheng Chih Jin, Laura Ibáñez, Sara Ortega‐Cubero, Pau Pástor, Jiyoon Choi, Breanna Cooper, Joel S. Perlmutter, Carlos Cruchaga · 2016 · Molecular Neurodegeneration
94. Genetic variation within endolysosomal system is associated with late-onset Alzheimer’s disease
    Song Gao, Aaron Casey, Timothy J. Sargeant, Ville‐Petteri Mäkinen · 2018 · Brain
95. The role of Tumour Necrosis Factor in neuroinflammation associated with Parkinson’s disease and targeted therapies
    Amin, Ruhul, Quispe, Cristina, Docea, Anca Oana, Ydyrys, Alibek, Kulbayeva, Marzhan, Durna Daştan, Sevgi, Calina, Daniela, Sharifi-Rad, Javad · 2022 · Neurochemistry International
96. Gaucher-related synucleinopathies: The examination of sporadic neurodegeneration from a rare (disease) angle
    S. Pablo Sardi, Seng H. Cheng, Lamya S. Shihabuddin · 2015 · Progress in Neurobiology
97. Splicing: is there an alternative contribution to Parkinson’s disease?
    Valentina La Cognata, Velia D’Agata, Francesca Cavalcanti, Sebastiano Cavallaro · 2015 · Neurogenetics
98. The Identification of Alpha-Synuclein as the First Parkinson Disease Gene
    Robert Luke Nussbaum · 2017 · Journal of Parkinson s Disease
99. Parkinson's disease and mitophagy: an emerging role for LRRK2
    François Singh, Ian G. Ganley · 2021 · Biochemical Society Transactions
100. R1441G but not G2019S mutation enhances LRRK2 mediated Rab10 phosphorylation in human peripheral blood neutrophils
     Ying Fan, Raja Sekhar Nirujogi, Alícia Garrido, Javier Ruiz‐Martínez, Alberto Bergareche‐Yarza, Elisabet Mondragón Rezola, Ana Vinagre‐Aragón, Ioana M. Croitoru, Ana Gorostidi Pagola, Laura Paternain Markinez et al. · 2021 · Acta Neuropathologica